Skip to content

Clinical trials

Phase 1 Generalized Anxiety Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 1 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20091
20201
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Pfizer2
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Penn State University1
Texas Tech University1
Trinity Hypertension & Metabolic Research Institute1
University of Florida1
University of Massachusetts, Boston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder10
Anxiety Disorders2
Bipolar Disorder1
Major Depressive Disorder1
Mental Disorders1
Neurocognitive Disorders1
Obsessive-Compulsive Disorder1
Panic Disorder1
Phobia, Social1
Stress Disorders, Post-Traumatic1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.